Hecht Bethinsider trades

In SEC Form 4 filings, Hecht Beth is listed as See Remarks of Xeris Biopharma Holdings, Inc. (XERS). In the last 90 days, Hecht Beth sold $298.2K of Xeris Biopharma Holdings, Inc. (XERS) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
XERSXeris Biopharma Holdings, Inc.	See Remarks	2	Oct 2

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-01

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
XERSXeris Biopharma Holdings, Inc.	Oct 1	Oct 2	S	16,666	$9.41	Sale −$156,792	1,111,130	Yes	Form 4
XERSXeris Biopharma Holdings, Inc.	Sep 1	Sep 1	S	16,666	$8.49	Sale −$141,434	1,127,796	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.